# An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

> **NCT00092729** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 129 (actual)

## Conditions studied

- Dysmenorrhea

## Interventions

- **DRUG:** etoricoxib (MK0663)
- **DRUG:** Comparator: placebo (unspecified)
- **DRUG:** Comparator: naproxen sodium

## Key facts

- **NCT ID:** NCT00092729
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06-07
- **Primary completion:** 2002-12-06
- **Final completion:** 2002-12-06
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2024-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092729, "An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00092729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*